Assessment of prothrombotic risk in patients with Behçet's disease should include homocysteine plasma levels

J Rheumatol. 2001 Dec;28(12):2764-5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Behcet Syndrome / blood*
  • Behcet Syndrome / complications
  • Behcet Syndrome / genetics
  • Folic Acid / blood
  • Genetic Predisposition to Disease
  • Genotype
  • Homocysteine / blood*
  • Humans
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Oxidoreductases Acting on CH-NH Group Donors / genetics
  • Risk Factors
  • Thromboembolism / blood*
  • Thromboembolism / etiology
  • Thromboembolism / genetics
  • Vitamin B 12 / blood
  • Vitamin B 6 / blood

Substances

  • Homocysteine
  • Vitamin B 6
  • Folic Acid
  • Oxidoreductases Acting on CH-NH Group Donors
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Vitamin B 12